Dr. Inna Kleyman, MD

Dr. Kleyman practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Kleyman's NPI, 1912227760, was assigned on June 3, 2010. Dr. Kleyman graduated from SUNY Downstate Health Sciences University in 2010. Dr. Kleyman holds New York license 266004.

Dr. Kleyman's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Kleyman's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Kleyman is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Kleyman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleyman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kleyman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kleyman is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kleyman's licenses on file in 4 states: New York, Florida, Massachusetts and New Jersey.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache, muscle disease, muscle pain, fibromyalgia, and limb pain and muscle weakness among the conditions Dr. Kleyman treats.

CMS data shows 419 Medicare services from Dr. Kleyman across 13 procedure codes in 2024, for 232 Medicare patients. Medicare paid $45,431 for them.

CMS counts 232 Medicare patients who saw Dr. Kleyman in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kleyman's median patient age at 57, with 61% women.

In 2024, Dr. Kleyman wrote 713 Medicare Part D claims for 120 patients. 55% of them were for generic drugs. CMS names the drug for 597 of them, across 23 drugs with 11 or more claims each, at $2,606,574 in total drug cost. In 2023, CMS named 561 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kleyman for performance year 2024, reported through an alternative payment model (APM). Dr. Kleyman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kleyman as offering telehealth.

Dmand AI links 5 papers to Dr. Kleyman, published from 2020 to 2024. Dr. Kleyman's most frequent co-authors are Louis Weimer, MD, Catherine Sw Albin, MD and Michelle Wilson Diana Bell, MD.

CMS Open Payments shows 176 general payments to Dr. Kleyman from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $665.

Dr. Kleyman graduated from SUNY Downstate Health Sciences University in 2010.

Dr. Kleyman is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.